Peter Maag heads Novartis Korea

Published: 2003-11-26 06:57:00

Updated: 2003-11-26 06:57:00

Novartis Korea, Korean unit of a multinational firm, has appointed Peter Maag as a new president following the transfer of Frank Bobe to vice president of Novatis Canada.

The congratulatory ceremony for the new president is scheduled to be held at 06:30 p.m. November 28 at J.W. Marriott Hotel ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK